435 related articles for article (PubMed ID: 22230652)
1. Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway.
Tong Y; Giaime E; Yamaguchi H; Ichimura T; Liu Y; Si H; Cai H; Bonventre JV; Shen J
Mol Neurodegener; 2012 Jan; 7():2. PubMed ID: 22230652
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of Parkinson's disease-linked leucine-rich repeat kinase 2.
Tong Y; Shen J
Biochem Soc Trans; 2012 Oct; 40(5):1042-6. PubMed ID: 22988862
[TBL] [Abstract][Full Text] [Related]
3. Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice.
Tong Y; Yamaguchi H; Giaime E; Boyle S; Kopan R; Kelleher RJ; Shen J
Proc Natl Acad Sci U S A; 2010 May; 107(21):9879-84. PubMed ID: 20457918
[TBL] [Abstract][Full Text] [Related]
4. Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo.
Albanese F; Mercatelli D; Finetti L; Lamonaca G; Pizzi S; Shimshek DR; Bernacchia G; Morari M
Neurobiol Dis; 2021 Nov; 159():105487. PubMed ID: 34419621
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
[TBL] [Abstract][Full Text] [Related]
6. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons.
Schapansky J; Khasnavis S; DeAndrade MP; Nardozzi JD; Falkson SR; Boyd JD; Sanderson JB; Bartels T; Melrose HL; LaVoie MJ
Neurobiol Dis; 2018 Mar; 111():26-35. PubMed ID: 29246723
[TBL] [Abstract][Full Text] [Related]
7. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.
Hu D; Niu JY; Xiong J; Nie SK; Zeng F; Zhang ZH
Curr Med Sci; 2018 Dec; 38(6):1012-1017. PubMed ID: 30536063
[TBL] [Abstract][Full Text] [Related]
8. LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice.
Herzig MC; Kolly C; Persohn E; Theil D; Schweizer T; Hafner T; Stemmelen C; Troxler TJ; Schmid P; Danner S; Schnell CR; Mueller M; Kinzel B; Grevot A; Bolognani F; Stirn M; Kuhn RR; Kaupmann K; van der Putten PH; Rovelli G; Shimshek DR
Hum Mol Genet; 2011 Nov; 20(21):4209-23. PubMed ID: 21828077
[TBL] [Abstract][Full Text] [Related]
9. Leucine-rich repeat kinase 2 deficiency is protective in rhabdomyolysis-induced kidney injury.
Boddu R; Hull TD; Bolisetty S; Hu X; Moehle MS; Daher JP; Kamal AI; Joseph R; George JF; Agarwal A; Curtis LM; West AB
Hum Mol Genet; 2015 Jul; 24(14):4078-93. PubMed ID: 25904107
[TBL] [Abstract][Full Text] [Related]
10. LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease.
Pang SY; Lo RCN; Ho PW; Liu HF; Chang EES; Leung CT; Malki Y; Choi ZY; Wong WY; Kung MH; Ramsden DB; Ho SL
Transl Neurodegener; 2022 Jan; 11(1):5. PubMed ID: 35101134
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic Parkinson's disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation.
Manzoni C; Mamais A; Dihanich S; McGoldrick P; Devine MJ; Zerle J; Kara E; Taanman JW; Healy DG; Marti-Masso JF; Schapira AH; Plun-Favreau H; Tooze S; Hardy J; Bandopadhyay R; Lewis PA
Biochem Biophys Res Commun; 2013 Nov; 441(4):862-6. PubMed ID: 24211199
[TBL] [Abstract][Full Text] [Related]
12. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.
Lin X; Parisiadou L; Gu XL; Wang L; Shim H; Sun L; Xie C; Long CX; Yang WJ; Ding J; Chen ZZ; Gallant PE; Tao-Cheng JH; Rudow G; Troncoso JC; Liu Z; Li Z; Cai H
Neuron; 2009 Dec; 64(6):807-27. PubMed ID: 20064389
[TBL] [Abstract][Full Text] [Related]
13. LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors.
Hinkle KM; Yue M; Behrouz B; Dächsel JC; Lincoln SJ; Bowles EE; Beevers JE; Dugger B; Winner B; Prots I; Kent CB; Nishioka K; Lin WL; Dickson DW; Janus CJ; Farrer MJ; Melrose HL
Mol Neurodegener; 2012 May; 7():25. PubMed ID: 22647713
[TBL] [Abstract][Full Text] [Related]
14. Modeling Parkinson's disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathway.
Albanese F; Domenicale C; Volta M; Morari M
Biochem Soc Trans; 2022 Feb; 50(1):621-632. PubMed ID: 35225340
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.
Streubel-Gallasch L; Giusti V; Sandre M; Tessari I; Plotegher N; Giusto E; Masato A; Iovino L; Battisti I; Arrigoni G; Shimshek D; Greggio E; Tremblay ME; Bubacco L; Erlandsson A; Civiero L
Mol Neurobiol; 2021 Jul; 58(7):3119-3140. PubMed ID: 33629273
[TBL] [Abstract][Full Text] [Related]
16. Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy body pathology.
Mamais A; Manzoni C; Nazish I; Arber C; Sonustun B; Wray S; Warner TT; Cookson MR; Lewis PA; Bandopadhyay R
Brain Res; 2018 Dec; 1701():75-84. PubMed ID: 30055128
[TBL] [Abstract][Full Text] [Related]
17. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.
Plowey ED; Cherra SJ; Liu YJ; Chu CT
J Neurochem; 2008 May; 105(3):1048-56. PubMed ID: 18182054
[TBL] [Abstract][Full Text] [Related]
18. Age-Dependent Dopaminergic Neurodegeneration and Impairment of the Autophagy-Lysosomal Pathway in LRRK-Deficient Mice.
Giaime E; Tong Y; Wagner LK; Yuan Y; Huang G; Shen J
Neuron; 2017 Nov; 96(4):796-807.e6. PubMed ID: 29056298
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice.
Pellegrini L; Hauser DN; Li Y; Mamais A; Beilina A; Kumaran R; Wetzel A; Nixon-Abell J; Heaton G; Rudenko I; Alkaslasi M; Ivanina N; Melrose HL; Cookson MR; Harvey K
Hum Mol Genet; 2018 Sep; 27(18):3257-3271. PubMed ID: 29917075
[TBL] [Abstract][Full Text] [Related]
20. LRRK2 and Proteostasis in Parkinson's Disease.
Pérez-Carrión MD; Posadas I; Solera J; Ceña V
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
